IGF1 and noise induced hearing loss: These findings suggested that USMBs improved the efficacy of topical administration of IGF-1 for the treatment of NIHL and that this combination resulted in a superior therapeutic effect against noise-induced cochlear damage, including the loss of outer hair cells and a reduction in the number of synaptic ribbons.